157 related articles for article (PubMed ID: 8523548)
1. Generation and role of defective proviruses in cytopathic feline leukemia virus (FeLV-FAIDS) infections.
de Noronha CM; Reinhart TA; Mullins JI
J Virol; 1996 Jan; 70(1):359-67. PubMed ID: 8523548
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning and characterization of a defective recombinant feline leukaemia virus associated with myeloid leukaemia.
Tzavaras T; Stewart M; McDougall A; Fulton R; Testa N; Onions DE; Neil JC
J Gen Virol; 1990 Feb; 71 ( Pt 2)():343-54. PubMed ID: 2155287
[TBL] [Abstract][Full Text] [Related]
3. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
[TBL] [Abstract][Full Text] [Related]
4. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.
McDougall AS; Terry A; Tzavaras T; Cheney C; Rojko J; Neil JC
J Virol; 1994 Apr; 68(4):2151-60. PubMed ID: 8138999
[TBL] [Abstract][Full Text] [Related]
5. Distinct superinfection interference properties yet similar receptor utilization by cytopathic and noncytopathic feline leukemia viruses.
Reinhart TA; Ghosh AK; Hoover EA; Mullins JI
J Virol; 1993 Sep; 67(9):5153-62. PubMed ID: 8394443
[TBL] [Abstract][Full Text] [Related]
6. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line.
Burns CC; Moser M; Banks J; Alderete JP; Overbaugh J
Virology; 1996 Aug; 222(1):14-20. PubMed ID: 8806483
[TBL] [Abstract][Full Text] [Related]
7. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV.
Overbaugh J; Hoover EA; Mullins JI; Burns DP; Rudensey L; Quackenbush SL; Stallard V; Donahue PR
Virology; 1992 Jun; 188(2):558-69. PubMed ID: 1316674
[TBL] [Abstract][Full Text] [Related]
8. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.
Rohn JL; Linenberger ML; Hoover EA; Overbaugh J
J Virol; 1994 Apr; 68(4):2458-67. PubMed ID: 8139030
[TBL] [Abstract][Full Text] [Related]
9. Replication kinetics and cell tropism of an immunosuppressive feline leukaemia virus.
Quackenbush SL; Mullins JI; Hoover EA
J Gen Virol; 1996 Jul; 77 ( Pt 7)():1411-20. PubMed ID: 8757981
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.
Terry A; Fulton R; Stewart M; Onions DE; Neil JC
J Virol; 1992 Jun; 66(6):3538-49. PubMed ID: 1316466
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a novel subgroup B feline leukemia virus from a cat infected with FeLV-A.
Boomer S; Gasper P; Whalen LR; Overbaugh J
Virology; 1994 Nov; 204(2):805-10. PubMed ID: 7941350
[TBL] [Abstract][Full Text] [Related]
12. In vivo evolution of a novel, syncytium-inducing and cytopathic feline leukemia virus variant.
Rohn JL; Moser MS; Gwynn SR; Baldwin DN; Overbaugh J
J Virol; 1998 Apr; 72(4):2686-96. PubMed ID: 9525586
[TBL] [Abstract][Full Text] [Related]
13. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.
Rohn JL; Lauring AS; Linenberger ML; Overbaugh J
J Virol; 1996 Nov; 70(11):8071-80. PubMed ID: 8892932
[TBL] [Abstract][Full Text] [Related]
14. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of endogenous feline leukemia virus sequences from a cat genomic library.
Soe LH; Devi BG; Mullins JI; Roy-Burman P
J Virol; 1983 Jun; 46(3):829-40. PubMed ID: 6304345
[TBL] [Abstract][Full Text] [Related]
16. Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses.
Donahue PR; Hoover EA; Beltz GA; Riedel N; Hirsch VM; Overbaugh J; Mullins JI
J Virol; 1988 Mar; 62(3):722-31. PubMed ID: 2828667
[TBL] [Abstract][Full Text] [Related]
17. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas.
Sheets RL; Pandey R; Jen WC; Roy-Burman P
J Virol; 1993 Jun; 67(6):3118-25. PubMed ID: 8388492
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes.
Helfer-Hungerbuehler AK; Widmer S; Kessler Y; Riond B; Boretti FS; Grest P; Lutz H; Hofmann-Lehmann R
Virus Res; 2015 Feb; 197():137-50. PubMed ID: 25553598
[TBL] [Abstract][Full Text] [Related]
19. Analysis of FeLV-FAIDS provirus burden and productive infection in lymphocyte subsets in vivo.
Quackenbush SL; Dean GA; Mullins JI; Hoover EA
Virology; 1996 Sep; 223(1):1-9. PubMed ID: 8806534
[TBL] [Abstract][Full Text] [Related]
20. Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.
Thomas E; Overbaugh J
J Virol; 1993 Oct; 67(10):5724-32. PubMed ID: 8396654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
